Inhibition of neuronal necroptosis via disruption of RIPK1-RIPK3 Interactions: The role of neural stem cell-derived exosomes in spinal cord injury recovery
Open Access
- 1 September 2025
- journal article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 51, 889-908
Abstract
Spinal cord injury (SCI) poses a significant economic and public health burden. Exosomes derived from neural stem cells (NSC-Exos) are emerging as a promising therapeutic strategy for SCI repair, overcoming several limitations associated with both autologous and allogeneic neural stem cell therapies. This study demonstrates that NSC-Exos are efficiently internalized by the injured spinal cord after co-injection, resulting in substantial motor function recovery in murine models. Additionally, NSC-Exos effectively limit the expansion of the injury site, reduce neuronal degeneration, and attenuate neuroinflammatory responses. Notably, this is the first study to identify necroptosis as a novel therapeutic target for NSC-Exos in SCI recovery. We show that NSC-Exos inhibit neuronal necroptosis both in vivo and in vitro by disrupting the RIPK1-RIPK3 interaction, thereby preventing necrosome assembly. Furthermore, comprehensive transcriptomic analysis reveals that the ubiquitin-mediated proteolysis (UPS) pathway plays a crucial role in this process, a finding supported by experimental inhibition of ubiquitination. In conclusion, this study highlights the therapeutic potential of NSC-Exos in SCI treatment, particularly through the inhibition of necroptosis via disruption of the RIPK1-RIPK3 interaction, potentially involving UPS activation. These findings provide a foundation for future investigations into the molecular mechanisms underlying SCI recovery.Keywords
Funding Information
- Guangdong Provincial Key Laboratory for Translational Cancer Research of Chinese Medicine, Guangzhou University of Chinese Medicine (ZDSYS20230626091402006)
- Science, Technology and Innovation Commission of Shenzhen Municipality (20231800939902)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20230807110259002)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20230807110310021)
- National Natural Science Foundation of China (82402846)
- National Natural Science Foundation of China (81801907)
- Shenzhen Science and Technology Innovation Program
- Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515140171)
- China Postdoctoral Science Foundation (GZC20242074)
- China Postdoctoral Science Foundation (2024M763788)
- Major Program of National Fund of Philosophy and Social Science of China
- Adolph C. and Mary Sprague Miller Institute for Basic Research in Science, University of California Berkeley
This publication has 64 references indexed in Scilit:
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Inhibition of Neural Stem Cell Necroptosis Mediated by RIPK1/MLKL Promotes Functional Recovery After SCIMolecular Neurobiology, 2023
- Polymer Physics-Based Classification of NeuronsNeuroinformatics, 2022
- Neuroplasticity of spinal cord injury and repair2022
- Isolate and Culture Neural Stem Cells from the Mouse Adult Spinal Cord2021
- A rationally designed self-immolative linker enhances the synergism between a polymer-rock inhibitor conjugate and neural progenitor cells in the treatment of spinal cord injuryBiomaterials, 2021
- Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF‐β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injuryJournal of Extracellular Vesicles, 2021
- Direct Neuronal Differentiation of Neural Stem Cells for Spinal Cord Injury RepairStem Cells, 2021
- Morphological Neuron Classification Based on Dendritic Tree HierarchyNeuroinformatics, 2018
- Role of ubiquitin ligases in neural stem and progenitor cellsArchivum Immunologiae et Therapiae Experimentalis, 2009